Effects of N-(2-Diethylaminoethyl)-N-(2-hydroxy- 2-phenylethyl)-2,5-dichloroaniline (AN 162) on Platelet Function and Blood Coagulation

Summary

When AN 162 was added to human citrated platelet-rich plasma at 30-300 µg/ml, it inhibited platelet aggregation induced by adenosine diphosphate, collagen, and thrombin. When AN 162 was given orally to guinea pigs at 30 to 100 mg/kg, an in vivo inhibitory effect on platelet aggregability was found. Though it activated platelet factor 3, the concentration of AN 162 required for substantial activation was greater than that for inhibition of platelet aggregation. No effect on plasma clotting factors was found at or below 300 µg/ml. Slight prolongation of whole blood clotting time was found in the rat and monkey.

• References

• 1 Adelson E, Crosby W. H. A new method to measure bleeding time. The “immersion” method. Actahaemat. (Basel) 18: 281-289 1957;
• 2 Born G. V. R, Mills D. C. B. Potentiation of the inhibitory effects of adenosine on platelet aggregation by drugs that prevent its uptake. J. Physiol. (Lond) 202: 41-42 1969;
• 3 Deutsch E. Private communication, and Thrombos. Diathes. haemorrh. (Stuttg) 26: 145 1971;
• 4 Deutsch E. Private communication.
• 5 Elkeles R. S, Hampton J. R, Honour A. J, Mitchell J. R. A, Pritchard J. S. Effect of a pyrimido-pyrimidine compound on platelet behavior in vitro and in vivo. Lancet II: 751-754 1968;
• 6 Evans G, Packham M. B, Nishizawa E. E, Mustard J. F, Murphy E. A. The effect of acetylsalicylic acid on platelet function. J. exp. Med 128: 877-894 1968;
• 7 Herrmann R. G, Frank J. D. Effect of adenosine derivatives and antihistamines on platelet aggregation. Proc. Soc. exp. Biol. (N. Y) 123: 654-660 1966;
• 8 Hovig T. Aggregation of rabbit blood platelets produced in vitro by saline “extract” of tendons. Thrombos. Diathes. haemorrh. (Stuttg) 09: 248-263 1963;
• 9 Langdeil R. D, Wagner R. H, Brinkhous K. M. Effect of antihemophilic factor on one-stage clotting tests. J. Lab. clin. Med 41: 637-647 1953;
• 10 Lewis R. E, Glueck H. I. A micromethod for determining clotting time, using capillary blood and siliconized tubes. J. Lab. clin. Med 52: 299-303 1958;
• 11 MacKenzie R. D, Blohm T. R, Auxier E. M, Henderson J. G, Steinbach J. M. Effects of a-(p-(fluoren-9-ylidenemethyl)phenyl)-2-piperidineethanol (RMI 10,393) on platelet function. Proc. Soc. exp. Biol. (N. Y) 137: 662-667 1971;
• 12 MacKenzie R. D, Blohm T. R, Auxier E. M. A modified Stypven test for the determination of platelet factor 3. Amer. J. clin. Path 55: 551-554 1971;
• 13 MacKenzie R. D, Blohm T. R, Steinbach J. M. In vivo effects of RMI 10,393 on platelet aggregation and blood coagulation. Biochem. Pharmacol. (To be published.)
• 14 MacKenzie R. D, Henderson J. G, Steinbach J. M. The evaluation of a method for adenosine diphosphate induced platelet aggregation in the guinea pig. Thrombos. Diathes. hae- morrh. (Stuttg) 25: 30-40 1971;
• 15 Mustard J. F, Hegardt B, Rowsell H. C, MacMillan R. L. Effect of adenosine nucleotides on platelet aggregation and clotting time. J. Lab. clin. Med 64: 548-559 1964;
• 16 Quick A. J, Stanley-Brown M, Bancroft F. W. Study of coagulation defect in hemophilia and in jaundice. Amer. J. med. Sci 190: 501-511 1935;
• 17 Zellner H. U.S. Patent. 3,300,532., Jan. 24, 1967